United States · FDA National Drug Code directory
Topiramate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-3461_c3bc6965-397a-4657-ae62-c05a29568265
- Product NDC
- 50090-3461
- Form
- TABLET
- Composition / generic term
- Topiramate
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140612
- Source listing expiry
- 20261231
Source-listed ingredients
- TOPIRAMATE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET in 1 BOTTLE (50090-3461-0) · 50090-3461-0
- 90 TABLET in 1 BOTTLE (50090-3461-1) · 50090-3461-1
- 120 TABLET in 1 BOTTLE (50090-3461-2) · 50090-3461-2
- 180 TABLET in 1 BOTTLE (50090-3461-3) · 50090-3461-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →